Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (171-180 of 330) with videos related to

Pageof 33
Sort By:
Cancer|October 10, 2022
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancerLaura E G Warren, Samuel M Niman, Marie C Remolano, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancerSonia Pernas, Jennifer L Guerriero, Sergey Naumenko, et al.
Journal of Geriatric Oncology|May 20, 2025
Patterns of presentation, treatment, and survival among older adults with metastatic breast cancer: Results from a large prospective registryAlexandra B Newman, Alyssa R Martin, Melissa E Hughes, et al.
Neuro-Oncology|August 30, 2024
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survivalAlyssa M Pereslete, Melissa E Hughes, Alyssa R Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Attitudes of patients with metastatic breast cancer toward research biopsiesD S Seah, S M Scott, J Najita, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancerPaolo Tarantino, Ogheneochuko Ajari, Noah Graham, et al.
Clinical Breast Cancer|October 22, 2019
Aggressive Subsets of Metastatic Triple Negative Breast CancerJasneet Singh, Sarah Asad, Yiqing Zhang, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
Nature Communications|March 19, 2022
p16<sup>INK4A</sup>-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastasesJing Ni, Sheheryar Kabraji, Shaozhen Xie, et al.
Breast (Edinburgh, Scotland)|October 11, 2016
Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective studyRomualdo Barroso-Sousa, Flavia Rocha Paes, Ines Vaz-Luis, et al.
Pageof 33

Showing results (171-180 of 330) with videos related to

Sort By:
Pageof 33
Cancer|October 10, 2022
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancerLaura E G Warren, Samuel M Niman, Marie C Remolano, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancerSonia Pernas, Jennifer L Guerriero, Sergey Naumenko, et al.
Journal of Geriatric Oncology|May 20, 2025
Patterns of presentation, treatment, and survival among older adults with metastatic breast cancer: Results from a large prospective registryAlexandra B Newman, Alyssa R Martin, Melissa E Hughes, et al.
Neuro-Oncology|August 30, 2024
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survivalAlyssa M Pereslete, Melissa E Hughes, Alyssa R Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Attitudes of patients with metastatic breast cancer toward research biopsiesD S Seah, S M Scott, J Najita, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancerPaolo Tarantino, Ogheneochuko Ajari, Noah Graham, et al.
Clinical Breast Cancer|October 22, 2019
Aggressive Subsets of Metastatic Triple Negative Breast CancerJasneet Singh, Sarah Asad, Yiqing Zhang, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
Nature Communications|March 19, 2022
p16<sup>INK4A</sup>-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastasesJing Ni, Sheheryar Kabraji, Shaozhen Xie, et al.
Breast (Edinburgh, Scotland)|October 11, 2016
Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective studyRomualdo Barroso-Sousa, Flavia Rocha Paes, Ines Vaz-Luis, et al.
Pageof 33